Latest News - CRSToday

Monday, February 12, 2018 | Clinical Trials, Retina, AMD

Phase 2 Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People with DME

Genentech announced encouraging results from the phase 2 BOULEVARD study. In people with vision loss from diabetic macular edema (DME), treatment with intravitreal RG7716 demonstrated clinically meani…

Read the full story

Friday, February 09, 2018 | Glaucoma

NEI Support Paved Early Pathway for Novel Glaucoma Therapies

The recent approval of two novel medications for glaucoma -- the first new medications for the disorder in nearly 18 years -- are fruit born from decades of foundational scientific research suppor…

Read the full story

Friday, February 09, 2018 | Glaucoma

Q Biomed Signs Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma

Q BioMed has announced an exclusive option agreement with Washington University in St. Louis. Under the agreement granting the exclusive right to license the technology, Q BioMed will evaluate the fea…

Read the full story

Friday, February 09, 2018 | Cornea

Researchers Design a New Intracorneal Inlay to Correct Presbyopia

Researchers at the Universitat Politècnica de València, University of Valencia, Instituto de Investigación Sanitaria La Fe and the companies AJL Ophthalmic SA and Aiken-Tecnolog…

Read the full story

Friday, February 09, 2018 | Awards

ASCRS Announces 2018 Ophthalmology Hall of Fame Inductees

The American Society of Cataract and Refractive Surgery (ASCRS) has announced that it will induct I. Howard Fine, MD, and the late David Maurice, PhD, into the ASCRS Ophthalmology Hall of Fame on Satu…

Read the full story

Thursday, February 08, 2018 | Glaucoma, Glaukos Corporation

Study: Glaukos iStent Reduced IOP and Lowered Medication Burden in Patients with Severe Glaucoma

Glaukos announced that a study published in the January 2018 issue of the Journal of Glaucoma showed that a single iStent Trabecular Micro-Bypass Stent implanted during cataract surgery in patients wi…

Read the full story

Wednesday, February 07, 2018 | Partnerships, Product Releases, Oculus

Oculus Pentacam AXL is Now Linked to the IOLcompass Pro Guidance System and TruePlan

Oculus and Leica Microsystems have informed surgeons that the new link to Leica’s Pro Guidance system and TrueVisions’ TruePlan is now ready to be purchased. As recently published, Oculus …

Read the full story

Wednesday, February 07, 2018 | Earnings & Financials, Allergan

Allergan's Profit Beats; Migraine Drug Succeeds in Key Study

Allergan on Tuesday reported a better-than-expected quarterly profit on strong demand for Botox, and said its migraine treatment met the main goals in a late-stage study. The key data could ease some …

Read the full story

Tuesday, February 06, 2018 | Product Releases, Quantel Medical

Quantel Medical Receives Japanese Approval for Easyret Photocoagulator Laser

Quantel Medical announced that it has received Japanese market approval for the new Easyret fully integrated 577nm yellow photocoagulator, which is used to treat certain forms of macular edema and per…

Read the full story

Tuesday, February 06, 2018 | Management/Leadership, Allergan

Allergan Names Matthew M. Walsh Executive Vice President and Chief Financial Officer

Allergan announced that Matthew M. Walsh has been appointed Executive Vice President and Chief Financial Officer. He will formally join Allergan later this month following a transition period from his…

Read the full story

Tuesday, February 06, 2018 | Medical Studies

CEOs, OD Speakers Join Program for Live Expo Event About Private Equity’s Impact on Optometry

OD speakers along with a panel of CEOs and executives from major private equity-backed vision care management companies will be on the program for the special live event to be held at Vision Expo East…

Read the full story

Monday, February 05, 2018 | Earnings & Financials, Second Sight Medical Products

Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant

Second Sight Medical Products provided a company update on the commercialization of its products, including the first-in-human implant of thee Orion Cortical Visual Prosthesis System. “We are…

Read the full story

Monday, February 05, 2018 | Clinical Trials, Dry Eye, Johnson & Johnson Vision Care

Johnson & Johnson Vision Announces Publication of Two Studies in Clinical Ophthalmology Demonstrating Effectiveness of LipiFlow as Treatment of MGD

Johnson & Johnson Vision announced the simultaneous publication of two studies in Clinical Ophthalmology demonstrating the patient and clinical benefits of LipiFlow treatment for meibomian gland d…

Read the full story

Monday, February 05, 2018 | Management/Leadership

EyePromise Announces Senior Leadership Changes

EyePromise and its parent company ZeaVision Holdings announced a series of organizational changes designed to help eye care practitioners manage their practices efficiently, effectively, and profitabl…

Read the full story

Monday, February 05, 2018 | Cataract Surgery, Clinical Trials, Eyegate Pharmaceuticals

EyeGate Announces Topline Results for Phase 2b Trial of EGP-437 in Cataract Surgery

EyeGate Pharmaceuticals announced topline results from a phase 2b study of EGP-437 combination product for pain and inflammation in patients having undergone cataract surgery. Although, EGP-437 demons…

Read the full story
Load More